Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.71 |
| ▸ | FYN | P06241 | 1/20 | 0.71 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.45 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
| ▸ | THRA | P10827 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PTGES | O14684 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18710473 | 0.87 | LCK (0.51) | LCKFYNTSHRHSD17B10LMNA | |
| SCHEMBL12085119 | 0.85 | TP53 (0.53) | LCKFYNTSHRHSD17B10TP53 | |
| SCHEMBL307832 | 0.84 | LCK (1.00) | LCKFYNTSHRHSD17B10KDM4E | |
| SCHEMBL13299048 | 0.84 | TP53 (0.48) | LCKFYNTP53CNR2SMPD1 | |
| SCHEMBL13299069 | 0.82 | KDM4E (0.51) | LCKFYNTP53CNR2SMPD1 | |
| SCHEMBL13257727 | 0.82 | KDM4E (0.51) | LCKFYNTP53CNR2SMPD1 | |
| SCHEMBL73150 | 0.82 | RARA (0.49) | LCKFYNTP53CNR2SMPD1 | |
| SCHEMBL8167721 | 0.81 | PTPN11 (0.61) | TSHRHSD17B10TP53PTPN11S1PR3 | |
| SCHEMBL10268417 | 0.80 | TSHR (0.51) | TSHRHSD17B10TP53PTPN11S1PR3 | |
| SCHEMBL17054339 | 0.79 | LCK (0.44) | LCKFYNTSHRHSD17B10TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7985879-B2 | reacting a 5-hydroxy-4-methoxy benzoic acid derivative with N-methyl-N-(2-[4-hydroxyphenyl]ethyl)amine, to form N-methyl-N-(2-[4-hydroxyphenyl]ethyl)-5-hydroxy-4-methoxy benzene carboxamide, which is useful as an intermediate in the synthesis of lycoremine | SCINOPHARM TAIWAN LTD. (TW) | 2011-07-26 | — | — | US | disclosed |
| US-20080255347-A1 | Process for making galantamine | SCINOPHARM TAIWAN LTD. | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255347-A1 | Process for making galantamine | GALR2, GALE, GALR1 | LCK 4656/4885FYN 2731/4885TSHR 3018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.